vs
FULLER H B CO（FUL）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
FULLER H B CO的季度营收约是Revvity的1.2倍（$892.0M vs $772.1M），Revvity净利率更高（12.7% vs 7.5%，领先5.2%），Revvity同比增速更快（5.9% vs -2.8%），Revvity自由现金流更多（$161.8M vs $68.9M），过去两年Revvity的营收复合增速更高（9.0% vs 5.0%）
H.B.富勒公司是总部位于美国明尼苏达州圣保罗的跨国粘合剂制造企业，全球第四大粘合剂及密封剂生产商。公司拥有超过20000种产品，广泛应用于建筑、工程、电子、卫生用品、食品包装等领域，在26个国家设有81座生产基地，2024年员工规模约7500人。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
FUL vs RVTY — 直观对比
营收规模更大
FUL
是对方的1.2倍
$772.1M
营收增速更快
RVTY
高出8.7%
-2.8%
净利率更高
RVTY
高出5.2%
7.5%
自由现金流更多
RVTY
多$92.9M
$68.9M
两年增速更快
RVTY
近两年复合增速
5.0%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $892.0M | $772.1M |
| 净利润 | $67.2M | $98.4M |
| 毛利率 | 32.0% | — |
| 营业利润率 | 12.3% | 14.5% |
| 净利率 | 7.5% | 12.7% |
| 营收同比 | -2.8% | 5.9% |
| 净利润同比 | 21.3% | 3.9% |
| 每股收益（稀释后） | $1.22 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FULRVTY
| Q4 25 | — | $772.1M | ||
| Q3 25 | $892.0M | $698.9M | ||
| Q2 25 | $898.1M | $720.3M | ||
| Q1 25 | — | $664.8M | ||
| Q4 24 | — | $729.4M | ||
| Q3 24 | $917.9M | $684.0M | ||
| Q2 24 | — | $691.7M | ||
| Q1 24 | $810.4M | $649.9M |
净利润FULRVTY
| Q4 25 | — | $98.4M | ||
| Q3 25 | $67.2M | $46.7M | ||
| Q2 25 | $41.8M | $53.9M | ||
| Q1 25 | — | $42.2M | ||
| Q4 24 | — | $94.6M | ||
| Q3 24 | $55.4M | $94.4M | ||
| Q2 24 | — | $55.4M | ||
| Q1 24 | $31.0M | $26.0M |
毛利率FULRVTY
| Q4 25 | — | — | ||
| Q3 25 | 32.0% | 53.6% | ||
| Q2 25 | 31.9% | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | 30.0% | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | 29.5% | 54.6% |
营业利润率FULRVTY
| Q4 25 | — | 14.5% | ||
| Q3 25 | 12.3% | 11.7% | ||
| Q2 25 | 11.1% | 12.6% | ||
| Q1 25 | — | 10.9% | ||
| Q4 24 | — | 16.3% | ||
| Q3 24 | 11.4% | 14.3% | ||
| Q2 24 | — | 12.4% | ||
| Q1 24 | 8.3% | 6.8% |
净利率FULRVTY
| Q4 25 | — | 12.7% | ||
| Q3 25 | 7.5% | 6.7% | ||
| Q2 25 | 4.7% | 7.5% | ||
| Q1 25 | — | 6.4% | ||
| Q4 24 | — | 13.0% | ||
| Q3 24 | 6.0% | 13.8% | ||
| Q2 24 | — | 8.0% | ||
| Q1 24 | 3.8% | 4.0% |
每股收益（稀释后）FULRVTY
| Q4 25 | — | $0.86 | ||
| Q3 25 | $1.22 | $0.40 | ||
| Q2 25 | $0.76 | $0.46 | ||
| Q1 25 | — | $0.35 | ||
| Q4 24 | — | $0.77 | ||
| Q3 24 | $0.98 | $0.77 | ||
| Q2 24 | — | $0.45 | ||
| Q1 24 | $0.55 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $122.5M | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.0B | $7.3B |
| 总资产 | $5.2B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FULRVTY
| Q4 25 | — | $919.9M | ||
| Q3 25 | $122.5M | $931.4M | ||
| Q2 25 | $96.8M | $991.8M | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | $131.4M | $1.2B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | $165.2M | $1.7B |
股东权益FULRVTY
| Q4 25 | — | $7.3B | ||
| Q3 25 | $2.0B | $7.4B | ||
| Q2 25 | $1.9B | $7.6B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.7B | ||
| Q3 24 | $1.8B | $7.9B | ||
| Q2 24 | — | $7.9B | ||
| Q1 24 | $1.8B | $7.8B |
总资产FULRVTY
| Q4 25 | — | $12.2B | ||
| Q3 25 | $5.2B | $12.1B | ||
| Q2 25 | $5.1B | $12.4B | ||
| Q1 25 | — | $12.4B | ||
| Q4 24 | — | $12.4B | ||
| Q3 24 | $5.0B | $12.8B | ||
| Q2 24 | — | $13.4B | ||
| Q1 24 | $4.7B | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $99.0M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $68.9M | $161.8M |
| 自由现金流率自由现金流/营收 | 7.7% | 21.0% |
| 资本支出强度资本支出/营收 | 3.4% | 2.6% |
| 现金转化率经营现金流/净利润 | 1.47× | 1.85× |
| 过去12个月自由现金流最近4个季度 | — | $509.4M |
8季度趋势，按日历期对齐
经营现金流FULRVTY
| Q4 25 | — | $182.0M | ||
| Q3 25 | $99.0M | $138.5M | ||
| Q2 25 | — | $134.3M | ||
| Q1 25 | — | $128.2M | ||
| Q4 24 | — | $174.2M | ||
| Q3 24 | $169.4M | $147.9M | ||
| Q2 24 | — | $158.6M | ||
| Q1 24 | $47.4M | $147.6M |
自由现金流FULRVTY
| Q4 25 | — | $161.8M | ||
| Q3 25 | $68.9M | $120.0M | ||
| Q2 25 | — | $115.5M | ||
| Q1 25 | — | $112.2M | ||
| Q4 24 | — | $149.8M | ||
| Q3 24 | $99.9M | $125.6M | ||
| Q2 24 | — | $136.6M | ||
| Q1 24 | $4.1M | $129.7M |
自由现金流率FULRVTY
| Q4 25 | — | 21.0% | ||
| Q3 25 | 7.7% | 17.2% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | — | 16.9% | ||
| Q4 24 | — | 20.5% | ||
| Q3 24 | 10.9% | 18.4% | ||
| Q2 24 | — | 19.7% | ||
| Q1 24 | 0.5% | 20.0% |
资本支出强度FULRVTY
| Q4 25 | — | 2.6% | ||
| Q3 25 | 3.4% | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | 7.6% | 3.3% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | 5.3% | 2.7% |
现金转化率FULRVTY
| Q4 25 | — | 1.85× | ||
| Q3 25 | 1.47× | 2.97× | ||
| Q2 25 | — | 2.49× | ||
| Q1 25 | — | 3.03× | ||
| Q4 24 | — | 1.84× | ||
| Q3 24 | 3.06× | 1.57× | ||
| Q2 24 | — | 2.87× | ||
| Q1 24 | 1.53× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FUL
| Hygiene Health And Consumable Adhesives | $386.1M | 43% |
| Engineering Adhesives | $272.3M | 31% |
| Building Adhesives Solutions | $233.7M | 26% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
